A safe low-cost pill that has actually shown to save the brain from atrophy with no need for brain imaging could help save governments billions in Alzheimer's future-related medical costs. This is likely also being weighed out in the approval process. Blarcamesine's slowing of Alzheimer's could help keep folks out of supportive care longer.
Market Data 
Markets 
AI
